Business Update
AEterna Zentaris' board approves upcoming special meeting
Published in Lab Law Weekly, November 24th, 2006
AEterna Zentaris, Inc., (AEZ; AEZS) a growing global biopharmaceutical company focused on endocrine therapy and oncology, announced that its board of directors has approved the convening of a Special Meeting of Shareholders on December 15, 2006 for the purpose of submitting to shareholders for their approval a resolution authorizing the distribution of all 11,052,996 subordinate voting shares of Atrium Biotechnologies held by AEterna Zentaris by way of reduction of the stated capital of AEterna Zentaris' common shares.
AEterna Zentaris' shareholders of record as of the close of business on November 14, 2006 will be entitled to receive notice of and vote at the Special...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
Source: Lab Law Weekly (2006-11-24)
More Articles from Lab Law Weekly
- Business & Finance
Emdeon announces preliminary third quarter results - Business & Finance
Enpath Medical reports 22% increase in third quarter revenues - Business & Finance
Fisher Scientific reports record quarterly financial results - Business & Finance
Nabi reports Q3 2006 revenue of $26.4 million, down from $30.5 million a year ago - Business Update
Clinical and financial impact of eICU Program presented at American College of Chest Physicians - Business Update
QLT announces third quarter results for 2006, updates guidance and implements cost reductions - More from this issue of Lab Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
